iTeos Therapeutics Inc

ITOSStocksBiotechnologyUnited StatesNasdaqUSD

Price

$10.05

Today

+0.0%

YTD

-1.0%

About

iTeos Therapeutics Inc is a global clinical-stage biopharmaceutical company specialising in the development and progression of cancer therapies. The company focuses on immuno-oncology and the improvement of clinical outcomes. Operating in the biotechnology and healthcare sector, iTeos Therapeutics Inc designs and develops novel product candidates that aim to restore the immune response against cancer. The company has a pipeline of products that includes two clinical-stage programs that target immuno-oncology pathways and optimise pharmacologic properties. Monitor the ITOS share price by adding it to your eToro watchlist.

Price chart

Closing price history for ITOS (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-2.09

P/S (TTM)0.00

P/B (TTM)0.91

Market cap$448.68M

Cap tierSmall-cap

Industry avg P/E-1.94

Profitability

Gross margin96.41%

EBIT margin0.00%

Net margin-20.37%

ROE-34.97%

ROA-29.44%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)-100.0%

EPS (TTM)-$4.85

Free cash flow$-108.69M

Total debt$5.13M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.96

Employees173

Next earnings12 Nov '25

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.